Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Get Free Report) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 119,902 shares, a decline of 45.2% from the April 30th total of 218,817 shares. Based on an average daily volume of 219,779 shares, the short-interest ratio is presently 0.5 days. Currently, 1.4% of the shares of the company are sold short.
Baird Medical Investment Stock Down 1.5%
NASDAQ:BDMD traded down $0.02 during trading hours on Wednesday, hitting $1.32. The stock had a trading volume of 27,849 shares, compared to its average volume of 1,310,231. The company has a 50 day simple moving average of $1.78 and a two-hundred day simple moving average of $1.61. Baird Medical Investment has a one year low of $0.76 and a one year high of $7.26.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of BDMD. Citadel Advisors LLC bought a new stake in Baird Medical Investment during the third quarter valued at approximately $99,000. Jane Street Group LLC bought a new position in shares of Baird Medical Investment in the 2nd quarter worth $142,000. Finally, Geode Capital Management LLC raised its position in shares of Baird Medical Investment by 59.7% during the 2nd quarter. Geode Capital Management LLC now owns 25,442 shares of the company’s stock valued at $93,000 after buying an additional 9,511 shares in the last quarter. 19.78% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Get Our Latest Analysis on Baird Medical Investment
Baird Medical Investment Company Profile
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Featured Stories
- Five stocks we like better than Baird Medical Investment
- Microsoft Build 2026 Is Really Just One Big AI Stress Test
- Slice of the Pie: Why Yum’s Deal Lifts QSR
- 3 Most Upgraded Stocks Last Month According to MarketBeat
- MongoDB Is the Latest SaaS Apocalypse Victim to Say “Not Today”
Receive News & Ratings for Baird Medical Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baird Medical Investment and related companies with MarketBeat.com's FREE daily email newsletter.
